1.Comparisons of minimally invasive esophagectomy and open esophagectomy in lymph node metastasis/dissection for thoracic esophageal cancer
Zhenhua LI ; Chunyue GAI ; Yuefeng ZHANG ; Shiwang WEN ; Huilai LV ; Yanzhao XU ; Chao HUANG ; Bo ZHAO ; Ziqiang TIAN
Chinese Medical Journal 2022;135(20):2446-2452
		                        		
		                        			
		                        			Background::The study aimed to clarify the characteristics of lymph node metastasis (LNM) and to compare the oncologic outcomes of minimally invasive esophagectomy (MIE) with open esophagectomy (OE) in terms of lymph node dissection (LND) in thoracic esophageal cancer patients.Methods::The data from esophageal cancer patients who underwent MIE or OE from January 2016 to January 2019 were retrospectively reviewed. The characteristics of LNM in thoracic esophageal cancer were discussed, and the differences in numbers of LND, LND rate, and LNM rate/degree of upper mediastinum between MIE and OE were compared.Results::For overall characteristics of LNM in 249 included patients, the highest rate of LNM was found in upper mediastinum, while LNM rate in middle and lower mediastinum, and abdomen increased with the tumor site moving down. The patients were divided into MIE ( n = 204) and OE groups ( n = 45). In terms of number of LND, there were significant differences in upper mediastinum between MIE and OE groups (8 [5, 11] vs. 5 [3, 8], P < 0.001). The comparative analysis of regional lymph node showed there was no significant difference except the subgroup of upper mediastinal 2L and 4L group (3 [1, 5] vs. 0 [0, 2], P < 0.001 and 0 [0, 2] vs. 0, P = 0.012, respectively). Meanwhile, there was no significant difference in terms of LND rate except 2L (89.7% [183/204] vs. 71.1% [32/45], P = 0.001) and 4L (41.2% [84/204] vs. 22.2% [10/45], P = 0.018) groups. For LNM rate of T3 stage, there was no significant difference between MIE and OE groups, and the comparative analysis of regional lymph node showed that there was no significant difference except 2L group (11.1% [5/45] vs. 38.1% [8/21], P = 0.025). The LNM degree of OE group was significantly higher than that of MIE group (27.2% [47/173] vs. 7.6% [32/419], P < 0.001), and the comparative analysis of regional LNM degree showed that there was no significant difference except 2L (34.7% [17/49] vs. 7.7% [13/169], P < 0.001) and 4L (23.8% [5/21] vs. 3.9% [2/51], P= 0.031) subgroups. Conclusion::MIE may have an advantage in LND of upper mediastinum 2L and 4L groups, while it was similar to OE in other stations of LND.
		                        		
		                        		
		                        		
		                        	
2.Geographical origin discriminant of Dendrobium officinale based on stable isotope ratios.
Jian YANG ; Hao WU ; Chao-Geng LV ; Sheng WANG ; Xiao-Bo ZHANG ; Guang YANG ; Lan-Ping GUO ; Lu-Qi HUANG
China Journal of Chinese Materia Medica 2018;43(6):1118-1123
		                        		
		                        			
		                        			The isotopic ratios of strontium isotope (Sr) and light elements (C/H/O/N) in Dendrobium officinale from different producing areas (Shaoguan, Guangdong; Yulin, Guangxi; Shibing, Guizhou; Wenshan, Yunnan and Zhejiang province) were determined with thermal ionization mass spectrometry (TI-MS) and isotope ratio mass spectrometry (IRMS).The differences of the stable isotope ratios in D. officinale were obtained by the variance analysis and the correlation analysis, and pattern recognition techniques with principal component analysis (PCA) was used to classify the geographical origins of D. officinale from different producing areas.The isotopic ratios of strontium isotope can be used to identified D. officinale in Zhejiang province, and the isotopic ratios of light elements showed the difference followed with the different producing areas. For δD and δ¹⁸ O in samples, maybe influenced by the environment effect. A positive correlation was found between δD and δ ¹⁸O.The principal component analysis was used to discern the samples of D. officinale from different producing areas based on detection technology of stable isotope ratios.These results revealed that it was possible and feasible to classify the geographical origin of D. officinale by the method of determination of isotopes,and provided a new method to identificate origin information of Chinese medicinal materials.
		                        		
		                        		
		                        		
		                        	
3.MicroRNA-708-3p as a potential therapeutic target via the ADAM17-GATA/STAT3 axis in idiopathic pulmonary fibrosis
Bo LIU ; Rongrong LI ; Jinjin ZHANG ; Chao MENG ; Jie ZHANG ; Xiaodong SONG ; Changjun LV
Experimental & Molecular Medicine 2018;50(3):e465-
		                        		
		                        			
		                        			 MicroRNAs (miRNAs) are important diagnostic markers and therapeutic targets for many diseases. However, the miRNAs that control the pathogenesis of idiopathic pulmonary fibrosis (IPF) and act as potential therapeutic targets for the disease are rarely studied. In the present study, we analyzed the function and regulatory mechanism of microRNA-708-3p (miR-708-3p) and evaluated this marker’s potential as a therapeutic target in IPF. The clinical and biological relevance of fibrogenesis for miR-708-3p was assessed in vivo and in vitro, specifically in matching plasma and tissue samples from 78 patients with IPF. The data showed that the miR-708-3p levels decreased during fibrosis and inversely correlated with IPF. The experiments showed that the decreased miR-708 promoter activity and primer-miR-708(pri-miR-708) expression were the potential causes. By computational analysis, a dual luciferase reporter system, rescue experiments and a Cignal Finder 45-Pathway system with siADAM17 and a miR-708-3p mimic, we identified that miR-708-3p directly regulates its target gene, a disintegrin and metalloproteinase 17 (ADAM17), through a binding site in the 3′ untranslated region, which depends on the GATA/STAT3 signaling pathway. Finally, an miR-708-3p agomir was designed and used to test the therapeutic effects of the miR-708-3p in an animal model. Small-animal imaging technology and other experiments showed that the dynamic image distribution of the miR-708-3p agomir was mainly concentrated in the lungs and could block fibrogenesis. In conclusion, the miR-708-3p–ADAM17 axis aggravates IPF, and miR-708-3p can serve as a potential therapeutic target for IPF. 
		                        		
		                        		
		                        		
		                        	
4.Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasion.
Yao-An WEN ; Bo-Wei ZHOU ; Dao-Jun LV ; Fang-Peng SHU ; Xian-Lu SONG ; Bin HUANG ; Chong WANG ; Shan-Chao ZHAO
Asian Journal of Andrology 2018;20(2):178-183
		                        		
		                        			
		                        			Phosphoglycerate mutase 1 (PGAM1) is upregulated in many cancer types and involved in cell proliferation, migration, invasion, and apoptosis. However, the relationship between PGAM1 and prostate cancer is poorly understood. The present study investigated the changes in PGAM1 expression in prostate cancer tissues compared with normal prostate tissues and examined the cellular function of PGAM1 and its relationship with clinicopathological variables. Immunohistochemistry and Western blotting revealed that PGAM1 expression was upregulated in prostate cancer tissues and cell lines. PGAM1 expression was associated with Gleason score (P = 0.01) and T-stage (P = 0.009). Knockdown of PGAM1 by siRNA in PC-3 and 22Rv1 prostate cancer cell lines inhibited cell proliferation, migration, and invasion and enhanced cancer cell apoptosis. In a nude mouse xenograft model, PGAM1 knockdown markedly suppressed tumor growth. Deletion of PGAM1 resulted in decreased expression of Bcl-2, enhanced expression of Bax, caspases-3 and inhibition of MMP-2 and MMP-9 expression. Our results indicate that PGAM1 may play an important role in prostate cancer progression and aggressiveness, and that it might be a valuable marker of poor prognosis and a potential therapeutic target for prostate cancer.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Apoptosis/genetics*
		                        			;
		                        		
		                        			Caspase 3/metabolism*
		                        			;
		                        		
		                        			Cell Line, Tumor
		                        			;
		                        		
		                        			Cell Movement/genetics*
		                        			;
		                        		
		                        			Cell Proliferation/genetics*
		                        			;
		                        		
		                        			Gene Deletion
		                        			;
		                        		
		                        			Gene Knockdown Techniques
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Matrix Metalloproteinase 2/metabolism*
		                        			;
		                        		
		                        			Matrix Metalloproteinase 9/metabolism*
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Mice, Nude
		                        			;
		                        		
		                        			Neoplasm Invasiveness/genetics*
		                        			;
		                        		
		                        			Neoplasm Transplantation
		                        			;
		                        		
		                        			PC-3 Cells
		                        			;
		                        		
		                        			Phosphoglycerate Mutase/genetics*
		                        			;
		                        		
		                        			Prostatic Neoplasms/pathology*
		                        			;
		                        		
		                        			Proto-Oncogene Proteins c-bcl-2/metabolism*
		                        			;
		                        		
		                        			RNA, Small Interfering
		                        			;
		                        		
		                        			Transplantation, Heterologous
		                        			;
		                        		
		                        			bcl-2-Associated X Protein/metabolism*
		                        			
		                        		
		                        	
5.Examination and assessment of target organ toxicity in toxicologic pathology of preclinical safety evaluation of drugs
tao Gui HUO ; iun Jian LV ; Zhi LIN ; Zhe QU ; wei Yan YANG ; Di ZHANG ; chao Xing GENG ; Yan HUO ; Xue WANG ; Bo LI
Drug Evaluation Research 2017;40(9):1235-1240
		                        		
		                        			
		                        			Examination and assessment of target organ toxicity in toxicologic pathology of preclinical safety evaluation of drugs should combine the results of the gross pathology,histopathology and clinical pathology examination data in a well-considered,stepwise approach.In addition,the nomenclature and diagnostic criteria recommended by INHAND should be used to avoid subjective and inappropriate diagnosis.In this paper,we briefly introduced the basic principles for the examination of organ toxicity in toxicology studies,gross pathology,histopathology,diagnostic approach,procedures,and considerations,international harmonization of diagnostic term and criteria,clinical pathology parameters analysis,results of a well-concerted combination of anatomical and clinical pathology data so as to provide some reference for the examination and assessment of target organ toxicity in toxicologic pathology in the field ofpreclinical safety evaluation of drugs in China.
		                        		
		                        		
		                        		
		                        	
6.Principles of necropsy and gross pathology examination for toxicologic pathology assessment
tao Gui HUO ; jun Jian LV ; Zhe QU ; Zhi LIN ; wei Yan YANG ; Di ZHANG ; Yan HUO ; chao Xing GENG ; Xue WANG ; Bo LI
Drug Evaluation Research 2017;40(10):1365-1371
		                        		
		                        			
		                        			Toxicologic pathology plays an important role in the safety evaluation of drugs.The results of toxicologic pathology can answer the basic problems of pathological lesions such as location,severity grading,nature and prognosis,etc.Necropsy and gross pathology examination are important aspects of toxicologic pathology assessment.Procedures typically include preparation for the necropsy,euthanasia procedures,identification and recording all gross lesions,collection of tissues listed in the study protocol,determination of organ weight,as well as tissue fixation so as to be ready for the subsequent tissue processing and histopathology examination.All the procedures must be done in a consistent manner and in accordance with standard operating procedures (SOPs).The present paper briefly introduced the principles of necropsy and gross pathology examination for toxicologic pathology in order to standardize the procedures and to lay foundation for the improvement of the histopathology examination in the field of preclinical safety evaluation of drugs of China.
		                        		
		                        		
		                        		
		                        	
7.Impact of premature rupture of membranes on neonatal complications in preterm infants with gestational age <37 weeks.
Shun-Yan DUAN ; Xiang-Yong KONG ; Feng-Dan XU ; Hong-Yan LV ; Rong JU ; Zhan-Kui LI ; Shu-Juan ZENG ; Hui WU ; Xue-Feng ZHANG ; Wei-Peng LIU ; Fang LIU ; Hong-Bin CHENG ; Yan-Jie DING ; Tie-Qiang CHEN ; Ping XU ; Li-Hong YANG ; Su-Jing WU ; Jin WANG ; Li PENG ; Xiao-Lin ZHAO ; Hui-Xian QIU ; Wei-Xi WEN ; Ying LI ; Lan LI ; Zheng WEN ; Guo GUO ; Feng WANG ; Gai-Mei LI ; Wei LI ; Xiao-Ying ZHAO ; Yun-Bo XU ; Wen-Chao CHEN ; Huan YIN ; Xiao-Liang WANG ; Rui-Yan SHAN ; Mei-Ying HAN ; Chun-Yan YANG ; Zhi-Chun FENG
Journal of Southern Medical University 2016;36(7):887-891
OBJECTIVETo investigate the effect of premature rupture of the membrane (PROM) on neonatal complications in premature infants.
METHODSThe registration information of 7684 preterm infants with gestational age <37 weeks were collected from the cooperative units in the task group between January 1, 2014 to December 31, 2014. Specially trained personnel from each cooperative units filled in the unified form in a standardized format to record the gender, gestational age, birth weight, PROM, placental abruption, antenatal corticosteroid, Apgar score, amniotic fluid pollution, and complications of the infants. The data were analyzed comparatively between the cases with PROM and those without (control).
RESULTSThe preterm mortality rate was significantly lower but the incidences of ICH, NEC, ROP and BPD were significantly higher in PROM group than in the control group (P<0.05). The 95% confidence interval of the OR value was <1 for mortality, and was >1 for ICH, NEC, ROP and BPD. After adjustment for gestational age, birth weight, gender, mode of delivery, placental abruption, placenta previa, prenatal hormones, gestational diabetes mellitus (GDM), gestational period hypertension and 5-min Apgar score <7, the incidences of NEC, ROP and BPD were significantly different between the two groups (P<0.05) with 95% confidence interval of OR value >1, but the mortality rate and incidence of ICH were not significantly different between the two groups (P>0.05).
CONCLUSIONPROM is a risk factor for NEC, ROP and BPD in preterm infants, and adequate intervention of PROM can reduce the incidences of such complications as NEC, ROP and BPD in the infants.
Apgar Score ; Birth Weight ; Female ; Fetal Membranes, Premature Rupture ; pathology ; Gestational Age ; Humans ; Incidence ; Infant, Newborn ; Infant, Newborn, Diseases ; etiology ; Infant, Premature ; Pregnancy ; Risk Factors
8.Chinese experts′consensus on protocol of breakpoints setting of new antibacterial agents for clinical trial
Yun LI ; Bo ZHENG ; Yuan LV ; Min-Ji WEI ; Ai-Lian SHAN ; Zhao-Long CAO ; Ruo-Yu LI ; Qin-Ping LIAO ; Ming-Gui LIN ; Xiao-Ju LV ; Xiao-Jun MA ; Yun-Xing NI ; Ming-Qing TONG ; Rui WANG ; Ying-Chun XU ; Xue-Fu YOU ; Jing ZHANG ; Qiong ZHANG ; Sui-Yang ZHANG ; Ming ZHAO ; Qing-Shan ZHENG ; Chao ZHUO
The Chinese Journal of Clinical Pharmacology 2015;(11):1069-1076
		                        		
		                        			
		                        			Clinical breakpoints are used in phaseⅡorⅢclinical trials to categorize microorganisms if susceptibility to new tested antibacterial agents that means the patient infected by the pathogen will be enrolled the study or not.The role of this consensus is to define procedure and required data to setting breakpoints and how to revaluate it in clinical trials.
		                        		
		                        		
		                        		
		                        	
9.Clinical effects of knee replacement postoperative reducing hemoglobin of tranexamic acid application
Fei XU ; Yong-Ming LV ; Ying-Chun SONG ; Xia LI ; En-Hong XING ; Yang YANG ; Yuan-Liang DU ; Li-Chao ZHANG ; Hai-Feng DAI ; Xiao-Qiang DONG ; Wen-Jing HE ; Yan-Bo ZHANG
The Chinese Journal of Clinical Pharmacology 2015;(13):1246-1248
		                        		
		                        			
		                        			Objective To investigate the effects of knee replacement postoperative on reducing hemoglobin by the different doses of tranexamic acid application.Methods A total of 116 knee replacement patients were enrolled and divided into the treatment group and the control group , 58 cases in each group .The surgical procedures and methods of the two groups were same , as patients in the control group were given intrave-nously before incision tranexamic acid 50 mg? kg -1 , and those in the treatment group received tranexamic acid 100 mg? kg -1 . During the peri-operative phase , the index of operation time , incision size , blood loss during operation , post -surgery drainage and the total number of blood transfusion , as well as hemoglobin were observed . Results Patients in two groups were all discharged after successful com-pletion surgery .The blood loss , postoperative drainage , the total amount of blood transfusion of the treatment group were significantly less than those of control group ( P<0.05 ) .The postoperative values in the two groups were showed significantly decreased ( P<0.05 ) , but preoperative hemoglobin values of the treatment group were significantly higher (P<0.05).The data of preoperative and postoperative coagulation indicators compared between two groups showed no significant difference .Patients were followed up for 3 months.The incidence of complications of deep vein thrombosis (1 case), acute myocardial infarction ( 0 case), transient neuro-logical symptom (1 case) in the treatment group were significantly lower than that in control group (5, 3, 4 cases) (P<0.05).Conclusion High dose of tranexamic acid applications can reduce blood loss and transfusion knee re -placement volume , and relieve the postoperative decrease of hemoglobin , meanwhile , it has no obvious effect on coagu-lation function with defined security .
		                        		
		                        		
		                        		
		                        	
10.Characteristics of Diprophylline-Induced Bidirectional Modulation on Rat Jejunal Contractility.
Fang Fei LIU ; Da Peng CHEN ; Yong Jian XIONG ; Bo Chao LV ; Yuan LIN
The Korean Journal of Physiology and Pharmacology 2014;18(1):47-53
		                        		
		                        			
		                        			In this study, we propose that diprophylline exerts bidirectional modulation (BM) on the isolated rat jejunal segment depending on its contractile state. The results supported the hypothesis. Diprophylline (20 microM) exerted stimulatory effects on the contractility of jejunal segment in six low contractile states while inhibitory effects in six high contractile states, showing the characteristics of BM. Diprophylline-induced stimulatory effect was significantly blocked by atropine, indicating the correlation with cholinergic activation. Diprophylline-induced inhibitory effect was partially blocked by phentolamine, propranolol, and L-N-Nitro-Arginine respectively, indicating their correlation with sympathetic activation and nitric oxide-mediated relaxing mechanisms. Diprophylline-induced BM was abolished by tetrodotoxin or in a Ca2+ free condition or pretreated with tyrosine kinase inhibitor imatinib, suggesting that diprophylline-induced BM is Ca2+ dependent, and that it requires the presence of enteric nervous system as well as pacemaker activity of interstitial cells of Cajal. Diprophylline significantly increased the reduced MLCK expression and myosin extent in constipation-prominent rats and significantly decreased the increased MLCK expression and myosin extent in diarrhea-prominent rats, suggesting that the change of MLCK expression may also be involved in diprophylline-induced BM on rat jejunal contractility. In summary, diprophylline-exerted BM depends on the contractile states of the jejunal segments, requires the presence of Ca2+, enteric nervous system, pacemaker activity of interstitial cells of Cajal, and MLCK-correlated myosin phosphorylation. The results suggest the potential implication of diprophylline in relieving alternative hypo/hyper intestinal motility.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Atropine
		                        			;
		                        		
		                        			Dyphylline
		                        			;
		                        		
		                        			Enteric Nervous System
		                        			;
		                        		
		                        			Gastrointestinal Motility
		                        			;
		                        		
		                        			Interstitial Cells of Cajal
		                        			;
		                        		
		                        			Myosins
		                        			;
		                        		
		                        			Phentolamine
		                        			;
		                        		
		                        			Phosphorylation
		                        			;
		                        		
		                        			Propranolol
		                        			;
		                        		
		                        			Protein-Tyrosine Kinases
		                        			;
		                        		
		                        			Rats*
		                        			;
		                        		
		                        			Tetrodotoxin
		                        			;
		                        		
		                        			Imatinib Mesylate
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail